The efficacy of Palivizumab prophylaxis for acute respiratory syncytial virus infections in at-risk populations: a literature review. Acervo Médico [Internet]. 2022 Sep. 17 [cited 2026 Nov. 3];17:e10854. Available from: https://acervomais.com.br/medico/article/view/10854